abc27

Delphi Diagnostics® Announces Four Abstracts and one General Session Presentation Featuring the Endocrine Activity Index™ to be Presented at the San Antonio Breast Cancer ...

HOUSTON, Nov. 4, 2025 /PRNewswire/ -- Delphi Diagnostics announces the upcoming presentation of four scientific abstracts, including one platform presentation highlighting new clinical data supporting ...
Morningstar

New Data Confirms Endocrine Activity Index® as a Predictor of Benefit from Dose-Dense Chemotherapy

HOUSTON, March 5, 2025 /PRNewswire/ -- Delphi Diagnostics, Inc. announces two important pieces of evidence to support the Endocrine Activity Index as a predictor of benefit from Dose-Intense ...
Business Wire

Delphi extends product portfolio for 632M vehicles globally with over 2,000 product launches

AUBURN HILLS, Mich.--(BUSINESS WIRE)--In line with its commitment to championing first-to-market innovations and market leading products, Delphi, a brand of PHINIA Inc., added over 2,000 new parts to ...
Morningstar

Delphi Diagnostics® Announces Four Abstracts and one General Session Presentation Featuring the Endocrine Activity Index™ to be Presented at the San Antonio Breast Cancer ...

Delphi Diagnostics, Inc. holds an exclusive license from The University of Texas MD Anderson Cancer Center in Houston, TX to commercialize the Endocrine Activity Index, a technology that was developed ...